Wemade Announces the Arrival of ‘Black Flame Arch Demon Nerkan’
Wemade, developer of the globally acclaimed MMORPG, MIR4, announces the arrival of a new world boss ‘Black Flame Arch Demon Nerkan’.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220307006056/en/
Wemade, developer of the globally acclaimed MMORPG, MIR4, announces the arrival of a new world boss ‘Black Flame Arch Demon Nerkan’. Black Flame Arch Demon Nerkan will appear every Tuesday at 7 pm in a sealed state on the fourth floor of Black Flame Abaddon in Redmoon Valley. Once the seal is released, the battle will begin; players with sufficient power and the courage to take on Nerkan will need to unite if they want to have a chance of defeating the Arch Demon. If Nerkan is defeated, players will acquire various items that will help them to grow. (Graphic: Business Wire)
Black Flame Arch Demon Nerkan will appear every Tuesday at 7 pm in a sealed state on the fourth floor of Black Flame Abaddon in Redmoon Valley. Once the seal is released, the battle will begin; players with sufficient power and the courage to take on Nerkan will need to unite if they want to have a chance of defeating the Arch Demon. If Nerkan is defeated, players will acquire various items that will help them to grow, including epic Blue Dragon Statues, Enhancement Stones, and Skill Tomes.
Meanwhile, recent updates such as Seoul Spooning 2022 and MIRAGE continue to expand the game’s economic endeavors as MIR4 strives to create a more advanced economy through utilizing blockchain technology.
A new game token, HYDRA, was unveiled through Seoul Spooning 2022 in January to expand the game’s blockchain functionality into the DeFi space. The HYDRA Staking Program (HSP) was also announced along with the implementation of various other economic policies. Further additions include a revolutionary NFT staking game, MIRAGE, which allows NFT characters from MIR4 to compete against each other in a web environment to mine Darksteel and Septaria and earn other rewards. This launch expanded the use of NFT characters as well as the economic development of MIR4. MIRAGE is the first instance of a secondary game built to utilize NFT characters that were obtained in MIR4 to obtain currency in MIRAGE that can then be transferred back to MIR4 – creating an inter-game economy.
MIR4 is Wemade’s representative P&E (Play and Earn) game, and through MIR4, Wemade plans the continuous introduction of a variety of new economic systems and game contents so that players can enjoy a more advanced economy and an immersive and fun gaming experience.
Reference
Wemade offers a global blockchain platform, WEMIX, on which games of all genres can be transformed into blockchain games. Many games are currently being serviced on WEMIX, and it aims to service 100 games whose key currency is WEMIX Token prior to 2022 year-end.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220307006056/en/
Contact information
Wemade Co., Ltd. (112040: KOSDAQ)
Yeonghyun Lee, PR Manager
yeonghyun@wemade.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 00:34:00 CET | Press Release
Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of the EIOS:VSE stock reflects this strength: Price per Share (PPS): +132% in the first half (H1) of 2025, stabilizing at a +116% YTD increase. Daily Trading Volume: peaks of
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 21:37:00 CET | Press Release
500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to strengthen Morocco’s innovation and digital competitiveness by accelerating high-potential founders and providing the training and financing pa
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press Release
Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218764112/en/ Image courtesy of Neural Concept (L-R clockwise from top) Jonathan Donier, CSO & Co-founder; Thomas von Tschammer, Managing Director US & Co-founder; Théophile Allard, CTO & Co-founder; Pierre Baqué CEO & Co-founder; Philippe Cuendet, COO Neural Concept is redefining engineering workflows with CAD-native enterprise AI that understands geometry, constraints and design intent. By helping its customers build and deploy physics-aware design copilots, the platform enables teams to explore millions of design options earlier and avoid costly la
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press Release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special? MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
